In the 1930s, Rudolf Peters showed that young rats kept on a semi-synthetic diet with added thiamin and riboflavin but no other supplement developed ‘rat acrodynia’, a condition characterized by severe cutaneous lesions. In 1934, Paul György showed that the factor which cured ‘rat acrodynia’ was vitamin B6. Other studies soon showed that vitamin B6 deficiency produced convulsions in rats, pigs, and dogs, and a microcytic anemia in certain animals. Samuel Lepkovsky isolated and crystallized vitamin B6 in 1938. The following year, Leslie Harris and Karl Folkers, and Richard Kuhn and his associates independently showed that vitamin B6 was a pyridine derivative, 3-hydroxy-4,5-dihydroxy-methyl-2-methyl-pyridine. György proposed the term pyridoxine for this derivative. Esmond Snell developed a microbiological growth assay in 1942 that led to the characterization of pyridoxamine, the animated product of pyridoxine, and pyridoxal, the formyl derivative of pyridoxine. Further studies showed that pyridoxal, pyridoxamine, and pyridoxine have largely equal activity in animals and owe their vitamin activity to the ability of the organism to convert them into the enzymatically active form pyridoxal-5-phosphate. Pyridoxal-5-phosphate plays a role in a wide variety of enzyme systems, especially in the metabolic utilization and transformation of amino acids.

1.
Reader V: The assay of vitamin B4. Biochem J 1930;24:1827–1831.
2.
Kinnersley HW, O’Brien JR, Peters RA, Reader V: Large scale preparations of vitamin B1 and vitamin B4 concentrates. Biochem J 1933;27:225–231.
3.
Kinnersley HW, O’Brien JR, Peters RA: Crystalline vitamin B1. Biochem J 1935;29:701–715.
4.
Gyorgy P: Vitamin B2 and the pellagra-like dermatitis in rats. Nature 1934;133:498.
5.
Chick H, Macrae TF, Martin AJ, Martin CJ: The water-soluble B-vitamins other than aneurin (vitamin B1), riboflavin and nicotinic acid required by the pig. Biochem J 1938;32:2207–2224.
6.
Chick H, El Sadr MM, Worden AN: Occurrence of fits of an epileptiform nature in rats maintained for long periods on a diet deprived of vitamin B6. Biochem J 1940;34:595–600.
7.
Wintrobe MM, Miller MH, Follis RH Jr, Stein HJ, Mushatt C, Humphreys S: Sensory neuron degeneration in pigs. IV. Protection afforded by calcium pantothenate and pyridoxine. J Nutr 1942;24:345.
8.
Fouts PJ, Helmer OM, Lepkovsky S, Jukes TH: Production of microcytic hypochromic anemia in puppies on synthetic diet deficient in rat antidermatitis factor (vitamin B6). J Nutr 1938;16:197–207.
9.
Jukes TH, Lepkovsky S: The distribution of the ‘filtrate factor’ (a water-soluble vitamin belonging to the vitamin B complex and preventing a dietary dermatitis in chicks) in certain feedingstuffs. J Biol Chem 1936;114:117–121.
10.
Birch TW: The reaction between vitamin B6 and the unsaturated fatty acid factor. J Biol Chem 1938;124:775–793.
11.
Lepkovsky S: Crystalline factor I. Science 1938;87:169–170.
12.
Keresztesy JC, Stevens JR: Vitamin B-6. J Am Chem Soc 1938;60:1267–1268.
13.
György P: Crystalline vitamin B-6. J Am Chem Soc 1938;60:983–984.
14.
Kuhn R, Wendt G: Über das aus Reiskleie und Hefe isolierte Adermin (Vitamin B6). Bericht Atsch Chem Ges 1938;71B:1118.
15.
Tchiba A, Michi K: Crystalline vitamin B-6. Sci Papers Inst Phys Chem Res (Tokyo) 1938;34:1014.
16.
Harris SA, Folkers K: Synthesis of vitamin B-6. J Am Chem Soc 1939;61:1245–1247.
17.
Kuhn R, Westphal K, Wendt G, Westphal O: Synthesis of adermine. Naturwissenschaften 1939;27:469.
18.
György P, Eckhardt RE: Vitamin B-6 and skin lesions in rats. Nature 1939;144:512.
19.
Snell EE, Guirard BM, Williams RJ: Occurrence in natural products of a physiologically active metabolite of pyridoxine. J Biol Chem 1942;143:519–530.
20.
Snell EE: Effect of heat sterilization on growth promoting activity of pyridoxine for Streptococcus lactis. Proc Soc Exp Biol Med 1942;51:356–358.
21.
Snell EE: The vitamin activities of ‘pyridoxal’ and ‘pyridoxamine’. J Biol Chem 1944;154:313–314.
22.
György P: The history of vitamin B6. Am J Clin Nutr 1956;4:313–317.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.